Technology and Equipment

Biopharma companies are rapidly making changes to their manufacturing strategies – and flexible downstream unit operation solutions are key.

How adding barcodes to glass containers can improve traceability.

A 70-year-old technique is helping to cut the development costs of monoclonal antibodies.

Let’s not forget the scientists working to improve efficiency and accuracy of the CRISPR – for they are key to unlocking its full potential.

We interview Johannes Khinast, CEO and Scientific Director of the Research Center for Pharmaceutical Engineering (RCPE), Graz, Austria.

Technology transfer is full of risks. But risks can be mitigated with the right strategy.

We catch up with Samsung Biologics about easing tech transfers and preparing plants for the future.

And the winner of The Medicine Maker 2020 Innovation Awards is…

A pair of medicines manufacturing initiatives are looking to improve continuous direct compression and clinical trial supply.

The increasing complexity of biologics raises significant manufacturing challenges – not least regarding cost control and downstream purification.